Going on a ketogenic diet might just be a sweet tooth's nightmare because this diet is all about eating food that is low in carbohydrates and high in fat.
This diet is preferred by many because it can help them shed off their belly fats, the fats that are hardest to get rid of.
Cutting down on sugar is one of the fastest ways to lose weight, according to health experts.
However, it is not easy staying true to a healthier lifestyle, and sometimes you just need the motivation to continue going through it.
Hence, many turn to their comfort food, which is often not healthy and are often sweet.
But, despair not because there are sweet food that you can still snack on, in moderate amounts of course, while staying true to the keto diet.
Dark chocolates are one that you can munch on, but you have to make sure they contain at least 70 percent of cocoa solids.
Or, you can also bake ketogenic energy balls using cocoa powder. One recipe for energy balls to try is the chocolate salted peanut butter, as suggested by the Daily Express.
You can even make this a regular addition to your keto diet because its fat and protein content are high.
According to a research, eating peanut butter might cause you to shed off some pounds.
Smoothies are sweet drinks that you can also have while on a keto diet. You just make sure that the ingredients you use, adhere to the keto diet such as avocado, coconut, berries, lemon, and lime. You can also add vanilla extract, cinnamon, or cacao for extra sweetness.
What is more, smoothies will make you feel full longer, thus lessening your food intake.
Or, you can also munch on the fruits if smoothies are not to your liking. Consuming half a cup of blackberries and raspberries will just give you four grams of sugar.
You can also bake yourself a chia pudding, which is rich in protein and fiber, making it a good fit for a keto diet.
Image credit courtesy of Theo Crazzolara/Flickr


Novo Nordisk Raises 2026 Outlook on Strong Wegovy Demand
Is dark chocolate healthier than milk chocolate? 2 dietitians explain
CDC Monitors U.S. Travelers After Hantavirus Outbreak on Luxury Cruise Ship
Moderna to Pay Up to $2.25B to Settle LNP Patent Dispute Over COVID-19 Vaccine Technology
Why the future of marijuana legalization remains hazy despite high public support
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review
Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
FDA Biologics Chief Vinay Prasad to Leave Agency in April Amid Policy Disputes
RFK Jr. Faces Scrutiny Over David Geier’s HHS Role and Vaccine Review Work
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales 



